CTRI/2023/02/049473尚未招募未知
Comparison of efficacy, safety, pharmacokinetic and pharmacodynamic parameters between conventional dosing regimen of vancomycin with novel optimized dosing regimen in critically ill patients.
Prof Nusrat Shafiq0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Critically ill adults admitted to intensive care unit or emergency ward where intravenous vancomycin therapy is deemed necessary based on suspected or confirmed infectious aetiology.
排除标准
- •Patients less than 18 years.
- •Patients requiring renal replacement therapy.
- •Patients with end stage renal disease.
- •Patients with end stage hepatic failure.
- •Any contraindication or history of hypersensitivity with use of vancomycin.
- •Pregnant and lactating women.
研究者
相似试验
进行中（未招募）
3 期
Comparative biosimilar rituximab vs Ristova in Rheumatoid ArthritisCTRI/2022/10/046212Virchow Biotech Private Limited
尚未招募
3 期
Comparative biosimilar Denosumab versus Xgeva in patients with bone metastasis from solid tumoursCTRI/2024/06/068269Virchow Biotech Private Limited
尚未招募
1 期
Evaluation of the effectiveness of platelet-rich plasma and microneedling platelet-rich plasma on the treatment of hair lossHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N6Skin and Stem Cell Research Center, Tehran University of Medical Sciences40
已完成
不适用
Effect of 10% Potassium hydroxide and 50% Trichloroacetic acid on plane wartsIRCT20170829035976N2Ahvaz University of Medical Sciences64
进行中（未招募）
1 期
A research study of how fast-acting insulin aspart works in the body of children, young people and grown-ups with type 1 diabetesDiabetes Mellitus, Type 1MedDRA version: 20.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861EUCTR2017-002014-31-DEovo Nordisk A/S43